R&I affirms Daiichi Sankyo's rating at "AA" and says negative outlook-R&I
Dec 1 (Reuters) - Daiichi Sankyo Co Ltd <4568.T>:Rating and Investment Information, Inc. (R&I) affirmed the company's rating at "AA"-R&I.Rating outlook negative-R&I.
Latest Developments forDaiichi Sankyo Co Ltd
Latest Key Developments inPharmaceuticals
- Sellas Life Sciences Group-On Dec. 5, Board Approved Termination Of License Agreement For GALE-401 Between Mills Pharmaceuticals & Biovascular
- Lupin Says EU General Court Upholds European Commission’S Decision In Perindopril Litigation
- AzurRx Biopharma To Acquire Payment Rights To Lead Drug Candidate MS1819-SD From Protea Biosciences Group
- India Market Regulator Chief Tyagi Says Examining Complaint Made Against Sun Pharma By Whistleblower - ET NOW